Regulated expression vectors demonstrate cell-type-specific sensitivity to human immunodeficiency virus type 1 Nef-induced cytostasis

Journal of General Virology

Volumn 78, Issue 2, 1997, Pages 381-392

  Cooke, Susan J ^a   Coates, Karen ^b   Barton, C Howard ^c   Biggs, Thelma E ^c   Barrett, Sarah J ^a   Cochrane, Alan ^d   Oliver, Kathryn ^e   McKeating, Jane A ^e   Harris, Mark P G ^b   Mann, Derek A ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HEAVY METAL; METALLOTHIONEIN; NEF PROTEIN; TETRACYCLINE;

ANIMAL CELL; ARTICLE; CYTOSTASIS; CYTOTOXICITY; EXPRESSION VECTOR; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; MACROPHAGE; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; VIRUS GENE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; MURINAE; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 15444345169     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-2-381     Document Type: Article

References (54)

1. Ackland-Berglund, C. E. & Leib, D. A. (1995). Efficacy of tetracycline-controlled gene expression is influenced by cell type. BioTechniques 18, 196-200.
2. Ahmad, N. & Venkatesan, S. (1988). Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241, 1481-1485.
3. Aiken, C. & Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. Journal of Virology 69, 5048-5056.
4. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E. & Trono, D. (1994). Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864.
5. Aldrovandi, G. M. & Zack, J. A. (1996). Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-Hu mice. Journal of Virology 70, 1505-1511.
6. Allan, J. S., Coligan, J. E., Lee, T., McLane, M. F., Kanki, P. J., Groopman, J. E. & Essex, M. (1985). A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230, 810-813.
7. Andersen, S., Shugars, D. C., Swanstrom, R. & Garcia, J. V. (1993). Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. Journal of Virology 67, 4923-4931.
8. Bandres, J. C. & Ratner, L. (1994). Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NFκB and AP-1 in human T cells in vitro after T-cell receptor stimulation. Journal of Virology 68, 3243-3249.
9. Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Cheng-Mayer, C. & Peterlin, B. M. (1994). HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384.
10. Benson, R. E., Sanfridson, A., Ottinger, J. S., Doyle, C. & Cullen, B. R. (1993). Downregulation of cell-surface CD4 expression by simian immunodeficiency virus nef prevents viral super infection. Journal of Experimental Medicine 177, 1561-1566.
11. Brady, H. J. M., Pennington, D. J., Miles, C. G. & Dzierzak, E. A. (1993). CD4 cell surface downregulation in HIV-1 nef transgenic mice is a consequence of intracellular sequestration. EMBO Journal 12, 4923-4932.
12. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J. S., Richman, D. D. & Guatelli, J. C. (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. Journal of Virology 68, 2906-2914.
13. Collette, Y., Chang, H. L., Cerdan, C., Chambost, H., Algarte, M., Mawas, C., Imbert, J., Burny, A. & Olive, D. (1996a). Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression. Journal of Immunology 156, 360-370.
14. Collette, Y., Dutartre, H., Benziane, A., Ramosmorales, F., Benarous, R., Harris, M. & Olive, D. (1996b). Physical and functional interaction of Nef with lck - HIV-1 Nef-induced T-cell signalling defects. Journal of Biological Chemistry 271, 6333-6341.
15. Clapham, P. R., McKnight. A. & Weiss, R. A. (1992). Human immunodeficiency virus type 2 infection and fusion of CD4-negative cell lines: induction and enhancement by soluble CD4. Journal of Virology 66, 3531-3537.
16. Clavel, F. & Charneau, P. (1994). Fusion from without directed by human immunodeficiency virus particles. Journal of Virology 68, 1179-1185.
17. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., Lawson, V. A., Crowe, S., Maerz, A., Sonza, S., Learmont, J., Sullivan, J. S., Cunningham, A., Dwyer, D., Dowton, D. & Mills, J. (1995). Genomic structure of an attenuated quasi-species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
18. Du, Z., Lang, S. M., Sasseville, V. G., Lackner, A. A., Ilyinskil, P. O., Daniel, M. D., Jung, J. U. & Desrosiers, R. C. (1995). Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82, 665-674.
19. Garcia, J. V. & Miller, A. D. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511.
20. Garcia, J. V., Alfano, J. & Miller, A. D. (1993). The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. Journal of Virology 67, 1511-1516.
21. Gossen, M. & Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences, USA 89, 5547-5551.
22. Greenway, A., Azad, A. & McPhee, D. (1995). Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. Journal of Virology 69, 1842-1850.
23. Guy, B., Kieny, M. P., Riviere, Y., le Peuch, C., Dott, K., Girard, M., Montagnier, L. & Lecocq, J. (1987). HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269.
24. Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R. & Greene, W. C. (1989). Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proceedings of the National Academy of Sciences, USA 86, 9549-9553.
25. Harris, M. P. G. & Neil, J. C. (1994). Myristoylation-dependent binding of HIV-1 Nef to CD4. Journal of Molecular Biology 241, 136-142.
26. Harris, M., Hislop, S., Patsilinacos, P. & Neil, J. C. (1992). In vivo derived HIV-1 nef gene products are heterogeneous and lack detectable nucleotide binding activity. AIDS Research and Human Retroviruses 8, 537-543.
27. Jamieson, B. D., Aldrovandi, G. M., Planelles, V., Jowett, J. B. M., Gao, L., Bloch, L. M., Chen, I. S. Y. & Zack, J. A. (1994). Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. Journal of Virology 68, 3478-3485.
28. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
29. Kim, S., Ikeuchi, K., Byrn, R., Groopman, J. & Baltimore, D. (1989). Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 86, 9544-9548.
30. Luciw, P. A., Cheng-Mayer, C. & Levy, J. A. (1987). Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proceedings of the National Academy of Sciences, USA 84, 1434-1438.
31. Luria, S., Chambers, I. & Berg, P. (1991). Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proceedings of the National Academy of Sciences, USA 88, 5326-5330.
32. McKeating, J. A., Bennett, J., Zolla-Pazner, S., Schutten, M., Ashelford, S., Leigh Brown, A. J. & Balfe, P. (1993). Resistance of a human serum selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120. Journal of Virology 67, 5216-5225.
33. Makarov, S. S., Jonat, C. & Haskill, S. (1994). Hyperinducible human metallothionein promoter with a low level basal activity. Nucleic Acids Research 22, 1504-1505.
34. Mariani, R. & Skowronski, J. (1993). CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proceedings of the National Academy of Sciences, USA 90, 5549-5553.
35. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C. & Feinberg, M. B. (1994). The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. Journal of Experimental Medicine 179, 101-113.
36. Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B. & Greene, W. C. (1995). Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. Journal of Virology 69, 579-584.
37. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55-63.
38. Murphy, K. M., Sweet, M. T., Ross, I. L. & Hume, D. A. (1993). Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. Journal of Virology 67, 6956-6964.
39. Myers, G., Korber, B., Hahn, B. H., Jeang, K. T., Mellors, J. W., McCutchan, F. E., Henderson, L. E. & Pavlakis, G. N. (editors) (1995). Human Retroviruses and AIDS 1995. Los Alamos, N. Mex.: Los Alamos National Laboratory.
40. Niederman, T. M. J., Thielan, B. J. & Ratner, L. (1989). Human immunodeficiency virus type I negative factor is a transcriptional silencer. Proceedings of the National Academy of Sciences, USA 86, 1128-1132.
41. Niederman, T. M., Garcia, J. V., Hastings, W. R., Luria, S. & Ratner, L. (1992). Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells. Journal of Virology 66, 6213-6219.
42. Niederman, T. M. J., Hastings, W. R., Luria, S., Bandres, J. C. & Ratner, L. (1993). HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 194, 338-344.
43. Raschke, W., Bairds, C., Ralph, R. & Nakoinz, I. (1978). Functional macrophage cell lines transformed by Abelson leukaemia virus. Cell 15, 261-267.
44. Rhee, S. S. & Marsh, J. W. (1994a). HIV-1 Nef activity in murine T cells: CD4 modulation and positive enhancement. Journal of Immunology 152, 5128-5134.
45. Rhee, S. S. & Marsh, J. W. (1994b). Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. Journal of Virology 68, 5156-5163.
46. Ryan-Graham, M. A. & Peden, K. W. C. (1995). Both virus and host components are important for the manifestation of a nef- phenotype in HIV-1 and HIV-2. Virology 213, 158-168.
47. Saksela, K., Cheng, G. & Baltimore, D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and arc required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO Journal 14, 484-491.
48. Schwarte, O., Dautry-Varsat, A., Goud, B., Marechal, V., Subtil, A., Heard, J. & Danos, O. (1995a). Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. Journal of Virology 69, 528-533.
49. Schwarte, O., Marechal, V., Danos, O. & Heard, J. M. (1995b). Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. Journal of Virology 69, 4053-4059.
50. Shugars, D. C., Smith, M. S., Glueck, D. H., Nantermet, P. V., Seillier-Moiseiwitsch, F. & Swanstrom, R. (1993). Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. Journal of Virology 67, 4639-4650.
51. Skowronski, J. & Mariani, R. (1995). Transient assay for Nef-induced down-regulation of CD4 antigen expression on the cell surface. In HIV: A Practical Approach, pp. 231-242. Edited by J. Karn. Oxford: Oxford University Press.
52. Skowronski, J., Parks, D. & Mariani, R. (1993). Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO Journal 12, 703-713.
53. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C. & Richman, D. D. (1994). The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. Journal of Experimental Medicine 179, 115-123.
54. Terwilliger, E., Sodroski, J. G., Rosen, C. A. & Haseltine, W. A. (1986). Effects of mutations within the 3′ orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. Journal of Virology 60, 754-760.